(Press-News.org) Inhaling nitric oxide gas does not reduce pain crises or shorten hospital stays in people living with sickle cell disease, according to the results of a new study sponsored by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health.
"Nitric Oxide for Inhalation in the Acute Treatment of Sickle Cell Pain Crisis," will be published in the March 2 issue of the Journal of the American Medical Association.
Sickle cell disease is an inherited disorder affecting between 70,000 and 100,000 Americans. The disease causes red blood cells, which are normally disc-shaped and pliable, to become misshapen, stiff and sticky. Severe pain crises occur periodically in people living with sickle cell disease when these sickled red blood cells hinder proper blood flow.
Nitric oxide dilates and expands blood vessels and enhances blood flow. Levels are lower in persons with sickle cell disease than in those without the disease. Previous trials with smaller numbers of patients had suggested that administration of nitric oxide might shorten sickle cell pain crises.
This study involved 150 sickle cell disease patients who were hospitalized for severe pain crises. Each participant was given nitric oxide gas or a placebo gas during treatment. Though the nitric oxide was well-tolerated, it failed to improve outcomes. The average length of pain crises among trial participants was 73 hours in the nitric oxide group compared with 65.5 hours in the placebo group, which was not statistically different. There was also no statistical difference between the two groups in average length of hospital stay or average painkiller usage.
INFORMATION:
Learn more about this trial at: http://clinicaltrials.gov/ct2/show/NCT00094887
Gregory Kato, M.D., head of NHLBI's Sickle Cell Vascular Disease Section and a co-author on this study, is available to comment on the study's findings and implications for future research.
For more information or to schedule an interview, contact the NHLBI Communications Office at 301-496-4236.
The National Heart, Lung, and Blood Institute (NHLBI) is a component of the
National Institutes of Health. NHLBI plans, conducts, and supports research related to the causes, prevention, diagnosis, and treatment of heart, blood vessel, lung, and blood diseases; and sleep disorders. The Institute also administers national health education campaigns on women and heart disease, healthy weight for children, and other topics. NHLBI press releases and other materials are available online at: www.nhlbi.nih.gov.
The National Institutes of Health (NIH) — The Nation's Medical Research Agency — includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical, and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.
END
Cannabis use during adolescence and young adulthood increases the risk of psychotic symptoms, while continued cannabis use may increase the risk for psychotic disorder in later life, concludes a new study published on bmj.com today.
Cannabis is the most commonly used illicit drug in the world, particularly among adolescents, and is consistently linked with an increased risk for mental illness. However, it is not clear whether the link between cannabis and psychosis is causal, or whether it is because people with psychosis use cannabis to self medicate their symptoms.
So ...
Postmenopausal women who smoke or used to smoke have up to a 16% higher risk of developing breast cancer compared to women who have never smoked, finds research published on bmj.com today.
The study also says that women who have had extensive exposure to passive smoking, either as children or in adulthood, may also have an excess risk of developing breast cancer.
While some previous studies have indicated that smoking increases the risk of breast cancer, the theory that passive smoking is also a risk factor, remains controversial.
The researchers, led by Dr Juhua ...
Have the suspension of central performance management of the 18 week referral to treatment target, and a relaxation of the four hour Accident and Emergency target, changed waiting times asks John Appleby, Chief Economist at the King's Fund in this week's BMJ?
The English National Health Service was once notorious for its excessive waiting times. In December 1999, nearly 160,000 patients were still waiting over six months for their first outpatient appointment and over 50,000 were still waiting over a year for a bed in hospital.
But since 2000, tough targets imposed ...
In the case of post-traumatic stress disorder, not all symptoms are created equal.
In an effort to better treat PTSD, a study published March 1 in the journal Psychiatric Services is the first to examine which problems associated with PTSD actually correspond to lower quality of life, as indicated by the patient's willingness to die sooner or to risk life-threatening treatment to relieve their symptoms.
PTSD is more costly than any other anxiety disorder. As many as 300,000 veterans returning from Iraq and Afghanistan currently have PTSD, with costs for their care estimated ...
DARIEN, IL – A new study in the March 1 issue of the journal Sleep indicates that the ability of children with attention deficit hyperactivity disorder to remain vigilant and attentive deteriorated significantly after losing less than one hour of nightly sleep for a week. The study suggests that even moderate reductions in sleep duration can affect neurobehavioral functioning, which may have a negative impact on the academic performance of children with ADHD.
Results of multivariate analyses of variance show that after mean nightly sleep loss of about 55 minutes for ...
Scientists at the UCSF Cardiovascular Research Institute have discovered how a change in growth hormone activity in mice leads to fatty liver disease, a condition whose human counterpart is of rising concern worldwide.
Disruption of a key protein in the pathway that responds to growth hormone could explain how fatty liver disease develops, the researchers said, but may also offer insights into how our bodies regulate fat in general.
The team's findings and the first reports of a mouse model to study the pathway will appear in the April issue of the Journal of Clinical ...
LA JOLLA, Calif., March 1, 2011 – When patients receive a bone marrow transplant, they are getting a new population of hematopoietic stem cells. Fresh stem cells are needed when a patient is low on red blood cells, as in anemia, or white blood cells, which can be caused by cancer or even cancer treatments such as irradiation or chemotherapy. The problem is that a bone marrow transplant might not succeed because the transplanted stem cells don't live long enough or because they proliferate too well, leading to leukemia.
To help determine how long a bone marrow (stem ...
A pioneering program by one of the world's largest cities to switch its vehicle fleet to clean fuel has not significantly improved harmful vehicle emissions in more than 5,000 vehicles – and worsened some vehicles' climate impacts – a new University of British Columbia study finds.
The study – which explores the impacts of New Delhi, India's 2003 conversion of 90,000 buses, taxis and auto-rickshaws to compressed natural gas (CNG), a well-known "clean" fuel – provides crucial information for other cities considering similar projects.
Of the city's more than 5,000 auto-rickshaws ...
Researchers at Karolinska Institutet have shown in a new study on mice, that cell therapy can be used to reverse the effect of 'bad' LDL cholesterol and reduce the inflammation that leads to atherosclerosis. The new cell therapy, which is presented in the prestigious scientific journal Circulation, can open the way for new therapies for stroke and myocardial infarction if the results prove translatable to humans.
Atherosclerosis is a chronic inflammation of the blood vessels. Cholesterol is transported in the blood in particles called LDL ('bad' cholesterol) that can ...
A new non-surgical post-mortem technique that has the potential to revolutionise the way autopsies are conducted around the world has been pioneered by forensic pathologists and radiologists at the University of Leicester in collaboration with the University Hospitals of Leicester NHS Trust.
The technique developed by a team in the East Midlands Forensic Pathology Unit, at the University of Leicester, has been published today (1 March) in International Journal of Legal Medicine. This paper presents the development of the methodology and protocol for this technique from ...
